Portfolio company
Moroxite F
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops regenerative medicine solutions to improve implant anchorage in osteoporotic bone for patients undergoing orthopaedic surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
GreenBone
This company produces rattan wood-derived bone substitutes for adult patients undergoing orthopedic surgery to treat severe bone defects and fractures.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
Moximed
This company develops implantable shock absorbers for patients with knee osteoarthritis to reduce joint load and delay the need for replacement surgery.
Preimure
This company develops antimicrobial polymer coatings for metallic medical implants to prevent infections in orthopaedic and traumatology patients.
Novadip
This company develops regenerative tissue products to treat large bone defects and spinal fusion for patients with limited treatment options.
Skeletalis
This biotechnology company develops bone-targeted small-molecule therapies for patients with osteoporosis and other musculoskeletal diseases.
Novadip Biosciences
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
